Ming C, Bai X, Zhao L, Yu D, Wang X, Wu Y
Front Oncol. 2023; 13:1131803.
PMID: 37920171
PMC: 10619668.
DOI: 10.3389/fonc.2023.1131803.
Harold C
Biosci Rep. 2023; 43(7).
PMID: 37335083
PMC: 10329186.
DOI: 10.1042/BSR20230631.
Kiparaki M, Baker N
Genetics. 2023; 224(3).
PMID: 37267156
PMC: 10691752.
DOI: 10.1093/genetics/iyad080.
Knight J, Proud C, Mallucci G, von der Haar T, Smales C, Willis A
J Invest Dermatol. 2022; 142(12):3346-3348.e1.
PMID: 35850210
PMC: 9708116.
DOI: 10.1016/j.jid.2022.06.019.
Surya A, Sarinay-Cenik E
Open Biol. 2022; 12(4):210308.
PMID: 35472285
PMC: 9042575.
DOI: 10.1098/rsob.210308.
Mutations in Hcfc1 and Ronin result in an inborn error of cobalamin metabolism and ribosomopathy.
Chern T, Achilleos A, Tong X, Hill M, Saltzman A, Reineke L
Nat Commun. 2022; 13(1):134.
PMID: 35013307
PMC: 8748873.
DOI: 10.1038/s41467-021-27759-7.
mutation suppresses colorectal cancer by promoting eEF2 phosphorylation via eEF2K.
Knight J, Vlahov N, Gay D, Ridgway R, Faller W, Proud C
Elife. 2021; 10.
PMID: 34895463
PMC: 8668188.
DOI: 10.7554/eLife.69729.
RNA-interference screen for p53 regulators unveils a role of WDR75 in ribosome biogenesis.
Moudry P, Chroma K, Bursac S, Volarevic S, Bartek J
Cell Death Differ. 2021; 29(3):687-696.
PMID: 34611297
PMC: 8901908.
DOI: 10.1038/s41418-021-00882-0.
Disruption of entire locus leads to embryonic lethality by diminished gene expression and enhanced p53 pathway.
Dinh T, Iseki H, Mizuno S, Iijima-Mizuno S, Tanimoto Y, Daitoku Y
Elife. 2021; 10.
PMID: 33949947
PMC: 8099427.
DOI: 10.7554/eLife.50346.
Puma- and Caspase9-mediated apoptosis is dispensable for p53-driven neural crest-based developmental defects.
Bowen M, Mulligan A, Sorayya A, Attardi L
Cell Death Differ. 2021; 28(7):2083-2094.
PMID: 33574585
PMC: 8257737.
DOI: 10.1038/s41418-021-00738-7.
Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death.
Domostegui A, Peddigari S, Mercer C, Iannizzotto F, Rodriguez M, Garcia-Cajide M
Blood. 2021; 137(24):3351-3364.
PMID: 33512431
PMC: 8212515.
DOI: 10.1182/blood.2020007452.
Transcriptomic Profiling of Human Pluripotent Stem Cell-derived Retinal Pigment Epithelium over Time.
Lidgerwood G, Senabouth A, Smith-Anttila C, Gnanasambandapillai V, Kaczorowski D, Amann-Zalcenstein D
Genomics Proteomics Bioinformatics. 2020; 19(2):223-242.
PMID: 33307245
PMC: 8602392.
DOI: 10.1016/j.gpb.2020.08.002.
Knockdown of GINS2 inhibits proliferation and promotes apoptosis through the p53/GADD45A pathway in non-small-cell lung cancer.
Chi F, Wang Z, Li Y, Chang N
Biosci Rep. 2020; 40(4).
PMID: 32181475
PMC: 7133113.
DOI: 10.1042/BSR20193949.
The p53 family reaches the final frontier: the variegated regulation of the dark matter of the genome by the p53 family in cancer.
Napoli M, Flores E
RNA Biol. 2020; 17(11):1636-1647.
PMID: 31910062
PMC: 7567494.
DOI: 10.1080/15476286.2019.1710054.
Inhibition of the 60S ribosome biogenesis GTPase LSG1 causes endoplasmic reticular disruption and cellular senescence.
Pantazi A, Quintanilla A, Hari P, Tarrats N, Parasyraki E, Dix F
Aging Cell. 2019; 18(4):e12981.
PMID: 31148378
PMC: 6612703.
DOI: 10.1111/acel.12981.
Impaired ribosome biogenesis: mechanisms and relevance to cancer and aging.
Turi Z, Lacey M, Mistrik M, Moudry P
Aging (Albany NY). 2019; 11(8):2512-2540.
PMID: 31026227
PMC: 6520011.
DOI: 10.18632/aging.101922.
The role of p53 in developmental syndromes.
Bowen M, Attardi L
J Mol Cell Biol. 2019; 11(3):200-211.
PMID: 30624728
PMC: 6478128.
DOI: 10.1093/jmcb/mjy087.
RP-MDM2-p53 Pathway: Linking Ribosomal Biogenesis and Tumor Surveillance.
Liu Y, Deisenroth C, Zhang Y
Trends Cancer. 2017; 2(4):191-204.
PMID: 28741571
PMC: 5531060.
DOI: 10.1016/j.trecan.2016.03.002.
p53 pathway is involved in cell competition during mouse embryogenesis.
Zhang G, Xie Y, Zhou Y, Xiang C, Chen L, Zhang C
Proc Natl Acad Sci U S A. 2017; 114(3):498-503.
PMID: 28049824
PMC: 5255589.
DOI: 10.1073/pnas.1617414114.
RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis.
Alkhatabi H, McLornan D, Kulasekararaj A, Malik F, Seidl T, Darling D
Oncotarget. 2016; 7(30):47875-47890.
PMID: 27374104
PMC: 5216985.
DOI: 10.18632/oncotarget.10293.